Skip Navigation

European Heart Journal 2003 24(23):2081-2082; doi:10.1016/j.ehj.2003.09.001
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Koning, E. J.P.
Right arrow Articles by Rabelink, Ton.J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Koning, E. J.P.
Right arrow Articles by Rabelink, Ton.J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Microvessel haemodynamics: interesting news which is not NO news?

Eelco J.P. de Koning and Ton.J Rabelink*

Department of Medicine, Division of Vascular Medicine, Diabetes and Endocrinology, F02.126, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

E-mail address: e.dekoning@azu.nl

* Corresponding author: Tel.: +31-30-2509111
E-mail address: t.rabelink@digd.azu.nl

Received 30 June 2003;

The first 10% of the full text of this article appears below.

See doi:10.1016/S1095-668X(03)00206-9for the article to which this editorial refers

Visceral obesity, a key factor of the metabolic syndrome and clinically to be recognized as an ‘apple-shape’ habitus and an increased waist circumference, is a strong predictor of cardiovascular events. There is a staggering increase in the prevalence of obesity in westernized societies in conjunction with an increase in type 2 diabetes and (sub)clinical atherosclerosis. From a clinical point of view, many regard type 2 diabetes as a vascular disease to express the seriousness of the ultimate atherosclerotic sequelae of the metabolic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?